Ionis Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | Outperform |
4
|
$314.72 | $303.65 | 1.68% | 8 | $168.83B |
| PFE | Pfizer | Outperform |
2
|
$28.92 | $32.87 | 5.46% | 6 | $163.88B |
| SAN | Sanofi | Outperform |
16
|
90.24€ | 102.80€ | 21.34% | 9 | 112.81€B |
| REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$967.98 | $961.26 | 8.47% | 8 | $104.43B |
| CSL | CSL | Outperform |
12
|
$286.95 | $205.51 | -28.44% | 5 | $138.67B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.48k | ¥5.24k | 8.54% | 0 | ¥10.51T |
| MRNA | Moderna | Outperform |
16
|
$132.68 | $135.42 | -5.03% | 1 | $50.85B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.14k | ¥4.74k | 8.75% | 0 | ¥6.49T |
| BIIB | Biogen | Outperform |
10
|
$230.04 | $299.62 | 25.41% | 13 | $33.49B |
| ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$151.22 | $245.24 | 43.83% | 7 | $19.13B |
| BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$76.97 | $111.56 | 43.56% | 5 | $14.62B |
| SRPT | Sarepta Therapeutics | Outperform |
6
|
$132.74 | $158.66 | 25.06% | 6 | $12.51B |
| INCY | Incyte | Outperform |
9
|
$56.86 | $77.05 | 38.06% | 8 | $12.01B |
| JAZZ | Jazz Pharmaceuticals | Outperform |
14
|
$110.49 | $188.32 | 70.15% | 4 | $7.13B |
| EXEL | Exelixis | Outperform |
16
|
$21.23 | $26.44 | 27.18% | 5 | $6.34B |
| NTLA | Intellia Therapeutics | Outperform |
8
|
$26.17 | $75.84 | 167.48% | 21 | $2.36B |
| DYN | Dyne Therapeutics | Buy |
5
|
$28.75 | $28.13 | 26.96% | 0 | $2.27B |
| DCPH | Deciphera Pharmaceuticals | Hold |
6
|
$25.45 | $23.40 | 2.16% | 4 | $2.19B |
| 4516 | Nippon Shinyaku | Outperform |
18
|
¥3.68k | ¥8.34k | 76.87% | 0 | ¥261.33B |
| BCRX | BioCryst Pharmaceuticals | Outperform |
7
|
$6.47 | $14.09 | 70.02% | 2 | $1.09B |
| WVE | Wave Life Sciences | Outperform |
6
|
$5.90 | $9.21 | 103.39% | 3 | $688.23M |
| PHARM | Pharming Group N.V. | Buy |
16
|
0.86€ | 1.85€ | 138.37% | 2 | 591.95€M |
| STOK | Stoke Therapeutics | Buy |
4
|
$14.03 | $19.33 | 42.55% | 3 | $604.59M |
| ABUS | Arbutus Biopharma | Outperform |
9
|
$2.89 | $6.34 | 89.62% | 0 | $535.96M |
| KALV | KalVista Pharmaceuticals | Buy |
7
|
$12.07 | $20.80 | 189.98% | 0 | $478.84M |
| FULC | Fulcrum Therapeutics | Outperform |
9
|
$7.80 | $10.21 | 85.90% | 7 | $456.83M |
| PYC | PYC Therapeutics | Buy |
8
|
$0.10 | $0.30 | 260.00% | 1 | $294.90M |